Products - Thyroid cancer | Topic | NICE

Showing 2 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Suspected Cancer: recognition and referral (update)
Status:
In development | In consultation
Programme:
NICE guideline
Consultation end date:
2 February 2026
Expected publication date:
25 March 2026
Selpercatinib for untreated RET-positive advanced thyroid cancer [ID6183]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC